You are here: Industry Insights > Medivir

News List

Medivir and SciLifeLab partner to identify Covid-19 drug candidates pharmaceutical-technology
July 07, 2020
Swedish drug development company Medivir has partnered with SciLifeLab, a life science research firm, to identify compounds with the potential to inhibit SARS-CoV-2, the novel coronavirus that causes Covid-19.
Medivir appoints new CMO biospectrum
September 12, 2018
Dr. Basse will report to CEO Christine Lind and join the Medivir Executive Team.
Medivir names Linda Basse as CMO, adding Darzalex R&D experience to its clinical team fiercebiotech
September 11, 2018
Medivir has named Linda Basse, M.D., Ph.D., as chief medical officer. The appointment puts a leader who played a starring role in the development of Darzalex in charge of ushering Medivir’s clinical pipeline through a critical period.
Medivir delays pivotal HDAC trial as FDA discussions stall fiercebiotech
June 25, 2018
A year ago, Medivir was riding high after reporting midstage data that encouraged it to press ahead with a pivotal trial of its HDAC inhibitor remetinostat in cutaneous T-cell lymphoma (CTCL).
Medivir offloads China rights for Hepatitic C drug to Ascletis biospectrumasia
August 22, 2017
The deal will help Ascletis build a robust pipeline of drugs for Hepatitis C
Medivir Initiates Study of Birinapant in Combination with KEYTRUDA americanpharmaceuticalreview
August 21, 2017
Medivir announced the first patient has been enrolled in the company's phase I/II study of birinapant in combination with the anti-PD-1 therapy KEYTRUDA (pembrolizumab), which is marketed by MSD. The objectives of the study are to evaluate the safety, tol
FDA Accepts Medivir´s IND Application for MIV-711 americanpharmaceuticalreview
August 17, 2017
Medivir announces the Investigational New Drug (IND) application for MIV-711 has been accepted and the IND is now open with the FDA (U.S. Food and Drug Administration).
Medivir completes phase II clinical study of skin cancer therapy biospectrumasia
April 10, 2017
CTCL is a chronic, orphan hematologic cancer that presents in the skin